National Comprehensive Cancer Network



About NCCN

Cervical Cancer Screening Panel - Disclosures as of 8/20/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Susana M. Campos, MD, MPH, MS

None

Boehringer Ingelheim GmbH

None

None

12/2/2013

Jeffrey Fowler, MD

GOG

None

None

None

11/19/2012

Rochelle L. Garcia, MD

None

None

None

None

5/24/2013

Anna R. Giuliano, PhD

None

Merck & Co., Inc.

None

None

1/31/2013

Howard W. Jones, III, MD

None

None

None

None

12/10/2012

Sarah Kim, MD

None

None

None

None

4/1/2013

Subodh M. Lele, MD

medelis, telormedix;
ventana

Medelis, Telormedix;
medelis; Telormedix;
Ventana

None

None

8/15/2014

Richard W. Lieberman, MD, FACOG, FACP

None

None

None

None

2/27/2013

Stewart L. Massad, MD

None

None

None

None

8/9/2012

Nikki Neubauer, MD

None

None

None

None

4/8/2013

Edward E. Partridge, MD

None

None

None

None

3/28/2013

R. Kevin Reynolds, MD

None

None

None

None

8/27/2013

Helen E. Rhodes, MD

None

None

None

None

2/26/2013

Joseph T. Santoso, MD

None

Jannsen Pharmaceutica Products, LP;
lab cor;
vermillion

None

None

1/20/2014

Karen Smith-McCune, MD, PhD

None

None

None

None

11/25/2009

Cornelia Liu Trimble, MD

None

None

None

None

1/23/2012

Fidel Valea, MD

None

Genentech, Inc.

UpToDate

None

5/5/2014

Sharon Wilczynski, MD

None

None

None

None

3/8/2013

Lourdes R. Ylagan, MD

None

None

None

None

9/10/2012